US Stock MarketDetailed Quotes

FBIOP Fortress Biotech Inc Series A P

Watchlist
  • 6.980
  • +0.180+2.65%
Close Jan 17 16:00 ET
  • 6.980
  • 0.0000.00%
Post 20:01 ET
352.23MMarket Cap0.00P/E (TTM)

About Fortress Biotech Inc Series A P Company

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Company Profile

SymbolFBIOP
Company NameFortress Biotech Inc Series A P
Listing DateDec 19, 2011
Founded2006
CEODr. Lindsay A. Rosenwald, M.D.
MarketNASDAQ
Employees186
Fiscal Year Ends12-31
Address1111 Kane Concourse,Suite 301
CityBay Harbor Islands
ProvinceFlorida
CountryUnited States of America
Zip Code33154
Phone1-781-652-4500
Websitehttp://www.fortressbiotech.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Lindsay A. Rosenwald, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 1.12M
  • David Jin
  • Principal Accounting Officer, Chief Financial Officer and Head, Corporate Development; Interim Chief Financial Officer and Chief Operating Officer of Avenue Therapeutics
  • 1.32M
  • Dr. George C. Avgerinos, PhD
  • Senior Vice President, Biologics Operations
  • --
  • Michael S. Weiss
  • Director and Executive Vice Chairman, Strategic Development
  • 962.66K
  • Dr. Eric K. Rowinsky,M.D.
  • Co-Vice Chairman and Director
  • 175.07K
  • Dr. Lucy Lu, M.D.
  • Director
  • 40.03K
  • Kevin L. Lorenz, J.D.
  • Independent Director
  • 40.03K
  • Dov Klein
  • Independent Director
  • 120.06K
  • Malcolm Hoenlein
  • Independent Director
  • 45.03K
  • Dr. Jimmie Harvey, Jr,M.D.
  • Independent Director
  • 67.57K
  • J. Jay Lobell
  • Independent Director
  • 87.57K
Heat List
US
Overall
Symbol
Price
% Chg

No Data